Per-1 is a specific clock gene regulated by parathyroid hormone (PTH) signaling in osteoblasts and is functional for the transcriptional events induced by PTH

Journal of Cellular Biochemistry

Volumn 112, Issue 2, 2011, Pages 433-438

  Hanyu, Ryo ^a,b   Hayata, Tadayoshi ^a   Nagao, Masashi ^a,b   Saita, Yoshitomo ^b   Hemmi, Hiroaki ^a   Notomi, Takuya ^a   Nakamoto, Tetsuya ^a   Schipani, Ernestina ^c   Knonenbery, Henry ^c   Kaneko, Kazuo ^b   Kurosawa, Hisashi ^b   Ezura, Yoichi ^a   Noda, Masaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

osteoblast; parathyroid hormone; Per 1

Indexed keywords

CIRCADIAN RHYTHM SIGNALING PROTEIN; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PERIOD CIRCADIAN PROTEIN 1; PROTEIN BMAL1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CYCLIC AMP RESPONSIVE ELEMENT; DRUG MECHANISM; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; MOUSE; NONHUMAN; OSTEOBLAST; POSITIVE FEEDBACK; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ABSORPTIOMETRY, PHOTON; ANIMALS; ARNTL TRANSCRIPTION FACTORS; BONE DENSITY; CELL LINE; CHEMOKINE CXCL12; MICE; MICE, TRANSGENIC; OSTEOBLASTS; PARATHYROID HORMONE; PERIOD CIRCADIAN PROTEINS; POLYMERASE CHAIN REACTION; RECEPTOR, PARATHYROID HORMONE, TYPE 1; X-RAY MICROTOMOGRAPHY;

MUS MUSCULUS;

EID: 79251603134     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22957     Document Type: Article

References (23)

1. Bjarnason GA, Jordan R,. 2000. Circadian variation of cell proliferation and cell cycle protein expression in man: Clinical implications. Prog Cell Cycle Res 4: 193-206.
2. Borba VZ, Mañas NC,. 2010. The use of PTH in the treatment of osteoporosis. Arq Bras Endocrinol Metabol 54: 213-219.
3. Bukata SV, Puzas JE,. 2010. Orthopedic uses of teriparatide. Curr Osteoporos Rep 8: 28-33.
4. Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R, Schipani E,. 2001. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 107: 277-286.
5. Canalis E,. 2010. New treatment modalities in osteoporosis. Endocrin Pract 29: 1-23.
6. de Crombrugghe B,. 2005. Osteoblasts clock in for their day job. Cell 122: 651-653.
7. de Paula FJ, Rosen CJ,. 2010. Back to the future: Revisiting parathyroid hormone and calcitonin control of bone remodeling. Horm Metab Res 42: 299-306.
8. Fu L, Patel MS, Karsenty G,. 2006. The circadian modulation of leptin-controlled bone formation. Prog Brain Res 153: 177-188.
9. Gallagher JC, Sai AJ,. 2010. Molecular biology of bone remodeling: Implications for new therapeutic targets for osteoporosis. Maturitas 65: 301-307.
10. Gallego M, virshup DM,. 2007. Post translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol 8: 139-148.
11. Giudice A, Caraglia M, Marra M, Montella M, Maurea N, Abbruzzese A, Arra C,. 2010. Circadian rhythms, adrenergic hormones and trafficking of hematopoietic stem cells. Expert Opin Ther Targets 14 (5): 567-575.
12. Hart SM, Eastell R,. 1999. Biochemical markers of bone turnover. Curr Opin Nephrol Hypertens 8: 421-427.
13. Hinoi E, Ueshima T, Hojo H, Iemata M, Takarada T, Yoneda Y,. 2006. Up-regulation of per mRNA expression by parathyroid hormone through a protein kinase A-CREB-dependent mechanism in chondrocytes. J Biol Chem 281: 23632-23642.
14. Kawai M, Rosen CJ,. 2010. PPARγ: A circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 6: 629-636.
15. Kondo H, Nifuji A, Takeda S, Ezura Y, Rittling SR, Denhardt DT, Nakashima K, Karsenty G, Noda M,. 2005. Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. J Biol Chem 280: 30192-30200.
16. Mizoguchi F, Izu Y, Hayata T, Hemmi H, Nakashima K, Nakamura T, Kato S, Miyasaka N, Ezura Y, Noda M,. 2010. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption. J Cell Biochem 109: 866-875.
17. Morinobu M, Nakamoto T, Hino K, Tsuji K, Shen ZJ, Nakashima K, Nifuji A, Yamamoto H, Hirai H, Noda M,. 2005. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation. J Exp Med 201: 961-970.
18. Ono N, Nakashima K, Rittling SR, Schipani E, Hayata T, Soma K, Denhardt DT, Kronenberg HM, Ezura Y, Noda M,. 2008. Osteopontin negatively regulates parathyroid hormone receptor signaling in osteoblasts. J Biol Chem 283: 19400-19409.
19. Ono N, Nakashima K, Schipani E, Hayata T, Ezura Y, Soma K, Kronenberg HM, Noda M,. 2007. Constitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorption. J Biol Chem 282: 25509-25516.
20. Schmitt CP, Hömme M, Schaefer F,. 2005. Structural organization and biological relevance of oscillatory parathyroid hormone secretion. Pediatr Nephrol 20: 346-351.
21. Silver J, Bushinsky D,. 2004. Harnessing the parathyroids to create stronger bones. Curr Opin Nephrol Hypertens 13: 471-476.
22. Trivedi R, Goswami R, Chattopadhyay N,. 2010. Investigational anabolic therapies for osteoporosis. Expert Opin Investig Drugs 19: 995-1005.
23. Wu M, Deng L, Zhu G, Li YP,. 2010. G Protein and its signaling pathway in bone development and disease. Front Biosci 15: 957-985.